FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA
%20Vaccine%20copy%202.jpg)
Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms, but can be serious for infants and older adults, resulting in an average of 60,000-160,000 hospitalizations and around 600-10,000 deaths per year in the US, with the highest death in people over 65. There is great news that on May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
Edusehat
Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. ||
An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.
.jpg)
